Evotec stock gains 9.51 percent over the week as results near

Published on 10/24/2026 at 10:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Evotec stock costs EUR 2.81 in weekend trading on October 24, 2026, versus EUR 2.81 at the October 23, 2026 Xetra close. Results arrive November 5, 2026.

Preliminary results set November date

Evotec reported preliminary revenue of EUR 465.0 million for the first nine months of 2026 on October 13, 2026.
Evotec stock trades in weekend trading at Lang & Schwarz at EUR 2.81 at 10:20 a.m. CEST on October 24, 2026, unchanged versus the Xetra close of October 23, 2026.
The next Xetra session is scheduled for October 26, 2026.

Isometrische 3D-Illustration einer Wirkstoffforschungs-Wertschöpfungskette mit Molekülen und Laborrobotern — Isometrische 3D-Grafik zeigt den Wirkstoffscreening-Prozess der Biotech-Branche von Evotec SE, ISIN DE0005664809, als Wertschöpfungskette, Illustration mit AI erstellt.

Evotec stock gained 9.51 percent over the five-day period through October 23, 2026, according to MarketScreener. The latest company disclosure in the period was Evotec SE’s preliminary nine-month results announcement dated October 13, 2026.

Market context: Market report DAX.

The week in figures

Evotec’s Xetra close was EUR 2.81 on October 23, 2026. MarketScreener reported a 5-day change of plus 9.51 percent through that session. The fetched quote data identifies Evotec SE as the issuer and EVT.DE as its Xetra-linked symbol.

Chronology of the week

On October 13, 2026, Evotec announced preliminary unaudited Group revenue of approximately EUR 465.0 million for the first nine months of 2026 and adjusted Group EBITDA of approximately minus EUR 42.8 million. The company said the figures were above current market expectations. The information was filed in Evotec SE’s Form 6-K and its attached ad hoc announcement, available through the SEC filing.

The same announcement reaffirmed full-year 2026 revenue guidance of approximately EUR 570 million to EUR 610 million and adjusted Group EBITDA guidance of approximately minus EUR 70 million to minus EUR 105 million. Evotec said full third-quarter and nine-month results are scheduled for publication on November 5, 2026.

Dates of the coming week

The next Xetra session is scheduled for October 26, 2026. Evotec’s full third-quarter and nine-month results are scheduled for November 5, 2026, according to the company’s October 13 announcement.

Weekend trading

Evotec trades in weekend trading at Lang & Schwarz at EUR 2.81 at 10:20 a.m. CEST on October 24, 2026. This matches the Xetra close of October 23, 2026. The further course of weekend trading at Lang & Schwarz until 1:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Evotec stock.